Polymers in Medical Devices: Opportunities for High Margins, Finds Frost & Sullivan

Polymers in Medical Devices: Opportunities for High Margins, Finds Frost & Sullivan PR Newswire LONDON, Aug. 8, 2012 - Innovative products addressing specific application needs poised to make strongest gains LONDON, Aug. 8, 2012 /PRNewswire/ -- Innovation, performance, quality and price are important factors influencing the use of polymers in medical devices. Although polymer prices are set to increase gradually, they are, nevertheless, expected to replace other materials like glass and metals. Therefore, the ability to engineer and customise polymers according to varied application needs will create lucrative opportunities. New analysis from Frost & Sullivan (http://www.chemicals.frost.com), Western European Market for Polymers in Medical Devices, finds that the market earned revenues of €602 million in 2011 and estimates this to reach €1075.4 million in 2018, boosted by the increasing replacement of other materials by polymers in medical devices. The research covers a range of product segments including polyvinyl chloride (PVC), silicone, styrene, thermoplastic elastomers and engineering and high performance polymers. "A rapidly greying population with its attendant healthcare needs will have a positive impact on the medical devices market and, by extension, on polymers used in such equipment," noted Frost & Sullivan Research Analyst Tridisha Goswami.